Picture of Althea group logo

AGH — Althea group News Story

au flag iconLast trade - 00:00
HealthcareAdventurousMicro CapValue Trap

RCS - Althea Group Hldgs. - European expansion and strategic growth plan


RNS Number : 2347S
Althea Group Holdings Limited
15 March 2021


15 March 2021



Althea Group Holdings Ltd (ASX:AGH)


Althea releases new investor presentation detailing European expansion and strategic growth plan


Investment Highlights:


·    ASX-listed global cannabis company with rapidly expanding operations in Europe, North America, Australia and Africa

·    Vertically integrated with capabilities spanning the manufacturing, sales and distribution of pharmaceutical and non-pharmaceutical cannabis-based products

·    Strong financial performance, news flow, and cash position

·    Massive market opportunity - undervalued against peer group



15 March 2021: Althea Group Holdings Limited (ASX:AGH) ('Althea' or 'the Company'), a global leader in the manufacturing, sales and distribution of pharmaceutical cannabis products and cannabis-based consumer packaged goods, is pleased to update the market on the Company's European Expansion and Strategic Growth Plan, the details of which are outlined in a new investor presentation accessible via this link.

Althea Group Holdings Ltd CEO, Joshua Fegan, said: "We are currently focused on strategically growing our footprint across the UK, Germany and other key European regions, including France, where we have recently been selected as a supplier for the French government's upcoming medicinal cannabis trial. With Europe expected to become the world's largest legal cannabis market over the next five years, we believe there has never been a more compelling and opportunistic time to be an Althea shareholder."


Authorised by: Robert Meissner, Company Secretary




 For further information, please contact:


Althea Group Holdings Ltd

Joshua Fegan                                          

CEO & Managing Director                                          

M: 1300 70 20 20                    

E: contact@althea.life                                      

Media Enquiries

Dan Francome

Media Relations

P: +613 9650 5096

E: dfrancome@althea.life

Investor Relations - AU

Julia Maguire

Investor Relations Partner

M: +61 2 8999 3699

E: julia@thecapitalnetwork.com.au   

Investor Relations - UK

Charles Goodwin

Investor Relations Partner

M: +44 (0)7747 788 221

E: althea@yellowjerseypr.com



Althea Group Holdings Limited (ASX:AGH)

Althea Group Holdings Ltd (ASX:AGH) is a global leader in the manufacturing, sales and distribution of pharmaceutical cannabis products and cannabis-based consumer packaged goods. Althea also offers a range of education, access and management services to support eligible patients and Healthcare Professionals in navigating medicinal cannabis treatment pathways.

Althea operates in highly regulated and legal cannabis markets across the world with burgeoning operations in Europe, North America, Australia and Africa.

To learn more, please visit: www.althea.life 


This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

Recent news on Althea group

See all news